Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu
Trial record 89 of 157 for:    (Dementia pugilistica OR chronic traumatic encephalopathy) AND Injuries

The Brave Initiative: Bringing Rehabilitation to American Veterans in an Enriched Environment (TBI)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT02339220
Recruitment Status : Active, not recruiting
First Posted : January 15, 2015
Last Update Posted : March 19, 2019
Sponsor:
Collaborator:
United States Department of Defense
Information provided by (Responsible Party):
Edward Taub, University of Alabama at Birmingham

Brief Summary:
The purpose of this study is to determine the value of Constraint-Induced Movement therapy (CIMT) for improving motor function and general fitness in adults with subacute and chronic traumatic brain injury (TBI), particularly TBI acquired during active military duty, in comparison to a Lakeshore Enriched Fitness Training (LEFT). The study will also test the effect of a set of enhanced versus "standard" procedures for transferring therapeutic gains from treatment setting to everyday life. Lastly, this study will determine whether any therapeutic effects observed are correlated with neuroplastic white matter or grey matter changes.

Condition or disease Intervention/treatment Phase
Traumatic Brain Injury Behavioral: Constraint-Induced Movement Therapy (CIMT) Behavioral: Lakeshore Enriched Fitness Training (LEFT) Behavioral: standard Transfer Package (sTP) Behavioral: enhanced Transfer Package (eTP) Not Applicable

Detailed Description:

The proposed project is a prospective, randomized, controlled, single-blind study comparing the motor improvements resulting from Constraint-Induced Movement Therapy (CIMT) and Lakeshore Enriched Fitness Training (LEFT) for traumatic brain injury (TBI) in veterans and civilians. Over the course of two years, there will be a total of 80 subjects randomly assigned to 4 conditions. Treatment, testing, and follow-up testing will be carried out in the first 3 grant years and the 1-year follow-up will be completed in the fourth year. Clinical testing will be conducted at pre-treatment, post-treatment, and 1-year follow-up. Longitudinal neuroimaging studies to determine the treatment change in white matter, grey matter, and functional brain connectivity will be carried out across the above-noted time points by different diffusion tensor imaging (DTI) analysis variants, voxel-based morphometry (VBM) analysis of structural magnetic resonance imaging (MRI) scans, analysis of resting state functional MRI (fMRI), and analysis of fMRI during hand movement.

The 80 study participants will be randomly assigned in equal numbers to 1 of 4 arms: CIMT with Standard Transfer Package (sTP), CIMT with Enhanced Transfer Package (eTP), LEFT with sTP or LEFT with eTP. Forty volunteers will be tested on average per year. The patients will be classified into mild/moderate (Grade 2) and moderate motor deficits (Grades 3); a classification made at the impairment level based on standard active range of motion (AROM) criteria (further elaborated in "Eligibility Criteria").

The primary clinical outcome will be pre- to post-treatment change in a measure of use of the more-affected arm in daily life known as the Motor Activity Log. It is described in the outcomes section. As noted above, the response of the brain to the interventions will be examined using structural grey matter MRI analysis, DTI, and fMRI during resting state and during arm movement.

Each participant will have the option of being accompanied by a caregiver (travel and living expenses paid for by the project). The caregiver will be asked to complete the MAL independently of the participant. The same questionnaire administered to the patient will be administered to the caregiver. In addition, the caregiver will be shown how to help the patient carry out the home practice exercises so that they can do this during treatment and afterwards (if they remain in close contact with the participant).


Layout table for study information
Study Type : Interventional  (Clinical Trial)
Estimated Enrollment : 80 participants
Allocation: Randomized
Intervention Model: Factorial Assignment
Masking: Single (Outcomes Assessor)
Primary Purpose: Treatment
Official Title: Harnessing Neuroplasticity to Promote Rehabilitation: Constraint-Induced (CI) Therapy for Traumatic Brain Injury (TBI)
Study Start Date : September 2016
Actual Primary Completion Date : January 2018
Estimated Study Completion Date : January 2020

Resource links provided by the National Library of Medicine


Arm Intervention/treatment
Experimental: Standard CI Therapy Group
This group will receive Constraint-Induced Movement Therapy (CIMT) with the Standard Transfer Package (sTP).
Behavioral: Constraint-Induced Movement Therapy (CIMT)
Constraint-Induced Movement Therapy (CIMT) is a form of physical rehabilitation based on basic research in behavioral psychology and behavioral neuroscience. The therapy will be given on an outpatient basis for 3.5 hours/day for 10 consecutive weekdays. This treatment has four components: 1. intensive training in use of the more-affected arm; 2. organization of this training following shaping principles, which involve frequent positive feedback and progressively increasing the demand of the task in small increments; 3. discouraging use of the less-affected arm by placing the hand in a padded safety mitt, and 4. a set of behavioral procedures, known as the Transfer Package, for transferring gains from the treatment to real-world setting. In this study, two forms of the Transfer Package, standard and enhanced, will be used and form a separate factor (see below).
Other Name: CI therapy

Behavioral: standard Transfer Package (sTP)
This intervention will take, on average, 30 minutes out of the 3.5 hour daily planned for treatment. The sTP is a set of behavioral procedures for transferring gains from the treatment setting to real-world. The procedures when the sTP is applied to CIMT include negotiating a behavioral contract with the patient and caregiver, when available, about use of each arm during the treatment period, keeping a daily diary on arm use, completing a structured interview about use of the more-affected arm in daily, problem solving about perceived barriers to use of the more-affected arm outside the treatment setting during treatment, and four weekly follow-up phone calls to assess use of the more-affected arm and problem solve about any remaining barriers perceived to its use. The sTP when applied to the LEFT intervention will have parallel components that target engagement in fitness activities and overcoming perceived barriers to fitness in the home.

Experimental: Enhanced CI Therapy Group
This group will receive CIMT with the enhanced Transfer Package (eTP).
Behavioral: Constraint-Induced Movement Therapy (CIMT)
Constraint-Induced Movement Therapy (CIMT) is a form of physical rehabilitation based on basic research in behavioral psychology and behavioral neuroscience. The therapy will be given on an outpatient basis for 3.5 hours/day for 10 consecutive weekdays. This treatment has four components: 1. intensive training in use of the more-affected arm; 2. organization of this training following shaping principles, which involve frequent positive feedback and progressively increasing the demand of the task in small increments; 3. discouraging use of the less-affected arm by placing the hand in a padded safety mitt, and 4. a set of behavioral procedures, known as the Transfer Package, for transferring gains from the treatment to real-world setting. In this study, two forms of the Transfer Package, standard and enhanced, will be used and form a separate factor (see below).
Other Name: CI therapy

Behavioral: enhanced Transfer Package (eTP)
This intervention will take, on average, 30 minutes out of the 3.5 hour daily planned for treatment. It is an enhanced form of the sTP. The enhancements include a computerized version of the daily diary, cues to be placed in patients' homes to prompt engagement in desired activities, and additional follow-up phone calls.

Active Comparator: Standard Fitness Training Group
This group will receive Lakeshore Enriched Fitness Training (LEFT) with the standard Transfer Package (sTP).
Behavioral: Lakeshore Enriched Fitness Training (LEFT)
This treatment will given on an outpatient basis for 3.5 hours per day for 10 consecutive weekdays. It will consist of the following components: general fitness exercises (largely lower extremity), sports and recreation (land and water-based); adapted Yoga; breathing exercises and postural control, movement to music, massage therapy, meditation and Progressive Muscle Relaxation (PMR).

Behavioral: standard Transfer Package (sTP)
This intervention will take, on average, 30 minutes out of the 3.5 hour daily planned for treatment. The sTP is a set of behavioral procedures for transferring gains from the treatment setting to real-world. The procedures when the sTP is applied to CIMT include negotiating a behavioral contract with the patient and caregiver, when available, about use of each arm during the treatment period, keeping a daily diary on arm use, completing a structured interview about use of the more-affected arm in daily, problem solving about perceived barriers to use of the more-affected arm outside the treatment setting during treatment, and four weekly follow-up phone calls to assess use of the more-affected arm and problem solve about any remaining barriers perceived to its use. The sTP when applied to the LEFT intervention will have parallel components that target engagement in fitness activities and overcoming perceived barriers to fitness in the home.

Active Comparator: Enhanced Fitness Training Group
This group will receive LEFT with the enhanced Transfer Package (eTP)
Behavioral: Lakeshore Enriched Fitness Training (LEFT)
This treatment will given on an outpatient basis for 3.5 hours per day for 10 consecutive weekdays. It will consist of the following components: general fitness exercises (largely lower extremity), sports and recreation (land and water-based); adapted Yoga; breathing exercises and postural control, movement to music, massage therapy, meditation and Progressive Muscle Relaxation (PMR).

Behavioral: enhanced Transfer Package (eTP)
This intervention will take, on average, 30 minutes out of the 3.5 hour daily planned for treatment. It is an enhanced form of the sTP. The enhancements include a computerized version of the daily diary, cues to be placed in patients' homes to prompt engagement in desired activities, and additional follow-up phone calls.




Primary Outcome Measures :
  1. Motor Activity Log [ Time Frame: From baseline to 19 days ]
    The Motor Activity Log (MAL) is a structured interview intended to examine how much and how well the subject uses their more-affected arm outside of the laboratory setting.


Secondary Outcome Measures :
  1. Accelerometry [ Time Frame: From baseline to 19 days ]
    Accelerometers are devices that monitor movement. Here, they will be worn on the wrist and measure amount of arm movement and overall physical activity.

  2. Accelerometry [ Time Frame: From baseline to 12-months ]
    Accelerometers are devices that monitor movement. Here, they will be worn on the wrist and measure amount of arm movement and overall physical activity.

  3. Motor Activity Log [ Time Frame: From baseline to 12-months ]
    See description of MAL under primary outcome measure.

  4. Six-Minute Walk/Push Wheelchair Test [ Time Frame: From baseline to 19 days ]
    This is a standard test of endurance and physical fitness. The distance walked or wheelchair is pushed in 6 minutes is measured.

  5. Six-Minute Walk/Push Wheelchair Test [ Time Frame: From baseline to 12-months ]
    This is a standard test of endurance and physical fitness. The distance walked or wheelchair is pushed in 6 minutes is measured.



Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Layout table for eligibility information
Ages Eligible for Study:   18 Years to 90 Years   (Adult, Older Adult)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

- Motor criteria will be made using an impairment-level system for characterizing the severity of an upper-extremity (UE) motor deficit based on Active Range of Motion (AROM). All UE motor criteria determinations will be made with the subject sitting. The more-affected forearm will be resting on a supporting surface (e.g. arm of chair) to allow for maximum wrist flexion with gravity. This study will treat patients at levels of Grade 2 (mild/moderate impairment) and Grade 3 (moderate impairment).

  • The minimum motor criterion (MMC) for inclusion in Grade 3 (moderate impairment) will be ability to:

    • Extend against gravity at least 10 degrees at the wrist from a fully flexed starting position
    • Extend two or more fingers at least 10 degrees at the metacarpophalangeal (MP) joint and either the proximal or distal interphalangeal (IP) joints
    • Extend or abduct the thumb at least 10 degrees
    • Extend the elbow at least 20 degrees from a 90 degree flexed starting position
    • Flex and abduct the shoulder at least 45 degrees
  • The MMC for inclusion in Grade 2 (mild/moderate impairment) will be ability to:

    • Extend against gravity at least 20 degrees at the wrist from a fully flexed starting position
    • Extend all fingers at least 10 degrees at the MP joint and either the proximal or distal IP joints
    • Extend or abduct the thumb at least 10 degrees
    • Extend the elbow at least 20 degrees from a 90 degree flexed starting position
    • Flex and abduct the shoulder at least 45 degrees
  • Additionally, subjects must have substantially reduced use of the extremity in the activities of daily living as indicated by a score of less than 2.5 on the Motor Activity Log (MAL).

Note: Each movement described above must be repeated 3 times in 1 minute.

Exclusion Criteria:

  • Those < 3 months post-TBI.
  • Excessive UE spasticity.
  • Insufficient stamina to carry out the requirements of the therapy (based on clinical judgment).
  • Medication (including psychoactive substances) will not be exclusionary except in the following cases: (If subjects are on other medications, the medications will be recorded and the possible effect on treatment outcome will be analyzed separately)

    • Participation in any experimental drug field study
    • Botox injections to the more-affected UE less than 3 months prior to participation
    • Baclofen or Dantrium taken orally at the time of study
  • Mini-Mental Status Exam (MMSE) score below 20.
  • Concurrent participation in any formal physical rehabilitation program or clinical trial.
  • Excessive pain in any joint of the more-affected extremity that could limit ability to cooperate with the intervention (based on clinical judgment).
  • Serious, uncontrolled medical problems (e.g., cardiovascular, severe rheumatoid arthritis, serious joint deformity of arthritic origin, symptomatic cancer or renal disease, any kind of end-stage pulmonary or cardiovascular disease, uncontrolled epilepsy) as judged by the Medical Director.
  • Other neurological or musculoskeletal conditions affecting UE function.
  • Unable to read or speak English.
  • Inadequate communication skills, i.e., not able to reliably understand questions or not able to express needs or report own behavior, to participate in study based on clinical judgment.
  • Substantial use of the more-affected arm in daily life as reflected by a Motor Activity Log score > 2.5.
  • Pain that interferes with use of the more-affected arm based on clinical judgment.
  • A positive pregnancy test will exclude participants from MRI scanning, but would not exclude them from clinical treatment.

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT02339220


Locations
Layout table for location information
United States, Alabama
University of Alabama at Birmingham
Birmingham, Alabama, United States, 35233
Sponsors and Collaborators
University of Alabama at Birmingham
United States Department of Defense
Investigators
Layout table for investigator information
Principal Investigator: Edward Taub, Ph.D. CI Therapy Research Group and Taub Training Clinic

Publications:
Layout table for additonal information
Responsible Party: Edward Taub, University Professor, University of Alabama at Birmingham
ClinicalTrials.gov Identifier: NCT02339220     History of Changes
Other Study ID Numbers: PT130232
First Posted: January 15, 2015    Key Record Dates
Last Update Posted: March 19, 2019
Last Verified: March 2019
Individual Participant Data (IPD) Sharing Statement:
Plan to Share IPD: Yes
Plan Description: Data will be shared via FITBIR site after trial has been unblinded and key outcome papers have been published.
Keywords provided by Edward Taub, University of Alabama at Birmingham:
Brain Injuries
Traumatic Brain Injury
Constraint-Induced Movement Therapy
Physical Therapy
Rehabilitation
Occupational Therapy
Fitness Training
Recovery of Function
Neuroplasticity
Exercise Therapy
Physical Therapy Modalities
Neuroimaging
Additional relevant MeSH terms:
Layout table for MeSH terms
Brain Injuries
Brain Injuries, Traumatic
Wounds and Injuries
Brain Diseases
Central Nervous System Diseases
Nervous System Diseases
Craniocerebral Trauma
Trauma, Nervous System